COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann; Farrukh T. Awan; Laura Fogliatto; Eugene Nikitin; Olga Samoilova; Adel Habib; Kayhan Foroutanpour; Nataliya Kuptsova-Clarkson; Stephen Opat

doi:10.1097/HS9.0000000000000780

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U. Niemann
, Farrukh T. Awan
, Laura Fogliatto
, Eugene Nikitin
, Olga Samoilova
, Adel Habib
, Kayhan Foroutanpour
, Nataliya Kuptsova-Clarkson
, Stephen Opat

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)

Original language	English
Article number	E780
Pages (from-to)	1-4
Number of pages	4
Journal	HemaSphere
Volume	6
Issue number	10
DOIs	https://doi.org/10.1097/HS9.0000000000000780
Publication status	Published - 22 Oct 2022

Access to Document

10.1097/HS9.0000000000000780Licence: CC BY-NC-ND

Cite this

@article{593b5fdc39714153b352e742e2fc2a5a,

title = "COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study",

author = "Niemann, \{Carsten U.\} and Awan, \{Farrukh T.\} and Laura Fogliatto and Eugene Nikitin and Olga Samoilova and Adel Habib and Kayhan Foroutanpour and Nataliya Kuptsova-Clarkson and Stephen Opat",

note = "Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca. ",

year = "2022",

month = oct,

day = "22",

doi = "10.1097/HS9.0000000000000780",

language = "English",

volume = "6",

pages = "1--4",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams \& Wilkins",

number = "10",

}

TY - JOUR

T1 - COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

AU - Niemann, Carsten U.

AU - Awan, Farrukh T.

AU - Fogliatto, Laura

AU - Nikitin, Eugene

AU - Samoilova, Olga

AU - Habib, Adel

AU - Foroutanpour, Kayhan

AU - Kuptsova-Clarkson, Nataliya

AU - Opat, Stephen

N1 - Funding Information: Writing and editorial assistance were provided by Robert J. Schoen, PharmD, and Laura L. McCormick, PhD, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca.

PY - 2022/10/22

Y1 - 2022/10/22

UR - https://www.scopus.com/pages/publications/85148937657

U2 - 10.1097/HS9.0000000000000780

DO - 10.1097/HS9.0000000000000780

M3 - Article

C2 - 36168519

AN - SCOPUS:85148937657

SN - 2572-9241

VL - 6

SP - 1

EP - 4

JO - HemaSphere

JF - HemaSphere

IS - 10

M1 - E780

ER -

COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Access to Document

Other files and links

Cite this